Application of riluzole- and borneol-containing composition in preparation of medication for treating cerebrovascular diseases
AssigneeNeurodawn Pharmaceutical Co., Ltd.
InventorsZhengping Zhang, Lei Wang, Rong Chen
Life of this patent
Estimating the term…
Abstract
A composition applied to preparation of a medicament for treating cerebrovascular diseases, in particular ischemic cerebrovascular diseases. The composition contains 2-amino-6-trifluoromethoxybenzothiazole or a pharmaceutically acceptable salt thereof and borneol. By means of the compatibility between 2-amino-6-trifluoromethoxybenzothiazole and d-borneol, according to non-clinical cell test and animal efficacy test results, for cerebrovascular diseases, 2-amino-6-trifluoromethoxybenzothiazole and d-borneol have the effect of synergistically increasing efficacy.
Claims8
A composition, comprising the following components:
- component (I), 2-amino-6-trifluoromethoxybenzothiazole, or a pharmaceutically acceptable salt thereof;
- and
- component (II), (+)-2-borneol.
Dependencies are inferred from the claim text.